Filing Details
- Accession Number:
- 0001232524-13-000106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-16 19:54:09
- Reporting Period:
- 2013-10-14
- Filing Date:
- 2013-10-16
- Accepted Time:
- 2013-10-16 18:54:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1394522 | K Jeffrey Tobias | C/O Jazz Pharmaceuticals Plc Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Evp, Research & Dev And Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2013-10-14 | 5,000 | $46.83 | 49,405 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2013-10-14 | 4,400 | $82.53 | 45,005 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2013-10-14 | 600 | $83.31 | 44,405 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nonstatutory Stock Option (right to buy) | Disposition | 2013-10-14 | 5,000 | $0.00 | 5,000 | $46.83 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 43,960 | 2022-08-08 | No | 4 | M | Direct |
Footnotes
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.08 to $82.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.21 to $83.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- This nonstatutory stock option is part of an option granted on August 9, 2012 that consisted of the nonstatutory stock option exercisable for 61,460 ordinary shares and an incentive stock option exercisable for 8,540 ordinary shares and has a vesting schedule of one fourth vested on August 9, 2013 and the remainder vesting in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
